Results 11 to 20 of about 235,111 (295)
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID‐19: Insight From a French Multicenter Cohort Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Coronavirus disease 2019 (COVID‐19) is a respiratory disease associated with thrombotic outcomes with coagulation and endothelial disorders. Based on that, several anticoagulation guidelines have been proposed.R. Chocron, V. Galand, J. Cellier, N. Gendron, T. Pommier, O. Bory, L. Khider, A. Trimaille, Guillaume Goudot, O. Weizman, J. Alsac, L. Geneste, Armand Schmeltz, V. Panagides, A. Philippe, W. Marsou, Iannis Ben Abdallah, A. Deney, S. El Batti, S. Attou, P. Juvin, Thomas Delmotte, E. Messas, T. Pezel, B. Planquette, B. Duceau, P. Gaussem, W. Sutter, O. Sanchez, V. Waldman, J. Diehl, T. Mirault, G. Bonnet, A. Cohen, D. Smadja +34 moresemanticscholar +3 more sourcesAnticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
New England Journal of Medicine, 2023 BACKGROUND
Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of AHREs in patients without atrial fibrillation (P. Kirchhof, Tobias Toennis, A. Goette, A. Camm, Hans-Christoph Diener, N. Becher, E. Bertaglia, Carina Blomstrom Lundqvist, M. Borlich, A. Brandes, N. Cabanelas, Melanie Calvert, G. Chlouverakis, G. Dan, J. D. de Groot, W. Dichtl, Borys Kravchuk, A. Lubiński, É. Marijon, B. Merkely, L. Mont, A. Ozga, K. Rajappan, A. Sarkozy, D. Scherr, R. Sznajder, V. Velchev, D. Wichterle, S. Sehner, E. Simantirakis, G. Lip, P. Vardas, U. Schotten, A. Zapf +33 moresemanticscholar +1 more sourceEarly versus Later Anticoagulation for Stroke with Atrial Fibrillation.
New England Journal of Medicine, 2023 BACKGROUND
The effect of early as compared with later initiation of direct oral anticoagulants (DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear.U. Fischer, M. Koga, D. Strbian, M. Branca, Stefanie Abend, S. Trelle, M. Paciaroni, G. Thomalla, P. Michel, K. Nedeltchev, L. Bonati, G. Ntaios, T. Gattringer, E. Sandset, Peter Kelly, R. Lemmens, P. Sylaja, Diana Aguiar de Sousa, N. Bornstein, Z. Gdovinová, T. Yoshimoto, M. Tiainen, Helen Thomas, M. Krishnan, G. Shim, C. Gumbinger, Jochen Vehoff, Liqun Zhang, K. Matsuzono, E. Kristoffersen, P. Desfontaines, P. Vanacker, Angelika Alonso, Y. Yakushiji, Caterina Kulyk, D. Hemelsoet, Sven Poli, Ana Paiva Nunes, N. Caracciolo, P. Slade, J. Demeestere, A. Salerno, M. Kneihsl, T. Kahles, Daria Giudici, Kanta Tanaka, S. Räty, Rea Hidalgo, D. Werring, Martina B. Göldlin, M. Arnold, Cecilia Ferrari, S. Beyeler, C. Fung, B. Weder, T. Tatlisumak, Sabine Fenzl, Beata Rezny-Kasprzak, A. Hakim, G. Salanti, C. Bassetti, J. Gralla, D. Seiffge, Thomas Horvath, Jesse Dawson +64 moresemanticscholar +1 more sourceTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine, 2021 Background Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill patients with Covid ...E. Goligher, C. Bradbury, B. McVerry, P. Lawler, J. Berger, M. Gong, M. Carrier, H. Reynolds, Ananda K Kumar, A. Turgeon, L. Kornblith, S. Kahn, J. Marshall, Keri S. Kim, Brett L. Houston, L. Derde, M. Cushman, T. Tritschler, D. Angus, L. C. Godoy, Z. McQuilten, B. Kirwan, M. Farkouh, M. Brooks, R. Lewis, L. Berry, E. Lorenzi, A. Gordon, S. Berry, C. McArthur, M. Neal, J. Hochman, S. Webb, R. Zarychanski, T. Ahuja, Farah Al-Beidh, D. Annane, Y. Arabi, Diptesh Aryal, Lisa Baumann Kreuziger, A. Beane, Zahra Bhimani, S. Bihari, H. Billett, Lindsay Bond, M. Bonten, F. Brunkhorst, M. Buxton, Adrian Buzgau, L. Castellucci, S. Chekuri, J. Chen, A. Cheng, T. Chkhikvadze, B. Coiffard, Aira Contreras, Todd W. Costantini, S. de Brouwer, M. Detry, A. Duggal, V. Džavík, M. Effron, H. Eng, J. Escobedo, L. Estcourt, Brendan M. Everett, D. Fergusson, M. Fitzgerald, R. Fowler, J. Froess, Zhuxuan Fu, J. Galanaud, B. Galen, S. Gandotra, T. Girard, A. Goodman, H. Goossens, Cameron Green, Y. Greenstein, P. Gross, R. Haniffa, Sheila M. Hegde, C. Hendrickson, A. Higgins, A. Hindenburg, A. Hope, J. Horowitz, Christopher M. Horvat, David T. Huang, Kristin M. Hudock, B. Hunt, M. Husain, R. Hyzy, J. Jacobson, Devachandran Jayakumar, N. Keller, Akram Khan, Yuri Kim, Andrei L. Kindzelski, A. King, M. Knudson, Aaron E. Kornblith, M. Kutcher, M. Laffan, F. Lamontagne, G. Le Gal, Christine M. Leeper, E. Leifer, G. Lim, Felipe Gallego Lima, K. Linstrum, E. Litton, J. López-Sendón, S. Lother, N. Marten, Andréa Saud Marinez, Mary Martinez, E. Mateos Garcia, Stavroula Mavromichalis, D. McAuley, E. McDonald, A. McGlothlin, S. McGuinness, S. Middeldorp, S. Montgomery, P. Mouncey, S. Murthy, G. Nair, Rahul R. Nair, A. Nichol, J. Nicolau, Brenda Nunez-Garcia, John J. Park, P. Park, R. Parke, Jane C. Parker, S. Parnia, J. Paul, M. Pompilio, J. Quigley, R. Rosenson, N. Rost, K. Rowan, F. O. Santos, Marlene S. Santos, M. O. Santos, L. Satterwhite, Christina T. Saunders, J. Schreiber, R. Schutgens, C. Seymour, D. Siegal, De Silva, A. Singhal, A. Slutsky, Dayna Solvason, S. Stanworth, Anne M Turner, Wilma van Bentum-Puijk, F. L. van de Veerdonk, S. van Diepen, Gloria Vázquez-Grande, Lana Wahid, Vanessa Wareham, R. Widmer, Jennifer G. Wilson, E. Yuriditsky, Yongqi Zhong +167 moresemanticscholar +1 more sourceSocial App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial
Cardiovascular Therapeutics, 2023 Background. Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it. Objective.Litao Zhang, Sha Li, Zishuo Li, Dan Yu, Haiyan Wu, Bing Hua, Li Xie, Xia Yuan, Yun Li, Zhenlu Zhang, Yanli Long +10 moredoaj +1 more sourceTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine, 2021 Background Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients P. Lawler, E. Goligher, J. Berger, M. Neal, B. McVerry, J. Nicolau, M. Gong, M. Carrier, R. Rosenson, H. Reynolds, A. Turgeon, J. Escobedo, David T. Huang, C. Bradbury, Brett L. Houston, L. Kornblith, Ananda K Kumar, S. Kahn, M. Cushman, Z. McQuilten, A. Slutsky, Keri S. Kim, A. Gordon, B. Kirwan, M. Brooks, A. Higgins, R. Lewis, E. Lorenzi, S. Berry, L. Berry, D. Angus, C. McArthur, S. Webb, M. Farkouh, J. Hochman, R. Zarychanski, A. Aday, Farah Al-Beidh, D. Annane, Y. Arabi, Diptesh Aryal, Lisa Baumann Kreuziger, A. Beane, Zahra Bhimani, S. Bihari, H. Billett, Lindsay Bond, M. Bonten, F. Brunkhorst, M. Buxton, Adrian Buzgau, L. Castellucci, S. Chekuri, J. Chen, A. Cheng, T. Chkhikvadze, B. Coiffard, Todd W. Costantini, S. de Brouwer, L. Derde, M. Detry, A. Duggal, V. Džavík, M. Effron, L. Estcourt, Brendan M. Everett, D. Fergusson, Mark E. Fitzgerald, R. Fowler, J. Galanaud, B. Galen, S. Gandotra, S. García-Madrona, T. Girard, L. C. Godoy, A. Goodman, H. Goossens, Cameron Green, Y. Greenstein, P. Gross, N. Hamburg, R. Haniffa, George Hanna, N. Hanna, Sheila M. Hegde, C. Hendrickson, R. D. Hite, A. Hindenburg, A. Hope, J. Horowitz, Christopher M. Horvat, Kristin M. Hudock, B. Hunt, M. Husain, R. Hyzy, V. Iyer, J. Jacobson, Devachandran Jayakumar, N. Keller, Akram Khan, Yuri Kim, Andrei L. Kindzelski, A. King, M. Knudson, Aaron E. Kornblith, V. Krishnan, M. Kutcher, M. Laffan, F. Lamontagne, G. Le Gal, Christine M. Leeper, E. Leifer, G. Lim, F. Lima, K. Linstrum, E. Litton, J. López-Sendón, J. L. López-Sendon Moreno, S. Lother, S. Malhotra, M. Marcos, Andréa Saud Marinez, J. Marshall, N. Marten, M. Matthay, D. McAuley, E. McDonald, A. McGlothlin, S. McGuinness, S. Middeldorp, S. Montgomery, S. Moore, Raquel Morillo Guerrero, P. Mouncey, S. Murthy, G. Nair, Rahul Nair, A. Nichol, Brenda Nunez-Garcia, A. Pandey, P. Park, R. Parke, Jane C. Parker, S. Parnia, J. Paul, Yessica S Pérez González, M. Pompilio, M. Prekker, J. Quigley, N. Rost, K. Rowan, F. O. Santos, Marlene S. Santos, Mayler Olombrada Santos, L. Satterwhite, Christina T. Saunders, R. Schutgens, C. Seymour, D. Siegal, De Silva, M. Shankar-Hari, J. Sheehan, A. Singhal, Dayna Solvason, S. Stanworth, T. Tritschler, Anne M Turner, Wilma van Bentum-Puijk, F. L. van de Veerdonk, S. van Diepen, Gloria Vázquez-Grande, Lana Wahid, Vanessa Wareham, Bryan J. Wells, R. Widmer, Jennifer G. Wilson, E. Yuriditsky, F. Zampieri +177 moresemanticscholar +1 more sourceEffect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
Journal of the American Medical Association (JAMA), 2021 Importance
Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic prophylaxis.P. Sadeghipour, Azita H. Talasaz, F. Rashidi, B. Sharif-Kashani, M. Beigmohammadi, Mohsen Farrokhpour, S. Sezavar, P. Payandemehr, Ali Dabbagh, K. G. Moghadam, Sepehr Jamalkhani, Hossein Khalili, M. Yadollahzadeh, T. Riahi, P. Rezaeifar, Ouria Tahamtan, S. Matin, Atefeh Abedini, Somayeh Lookzadeh, H. Rahmani, Elnaz Zoghi, Keyhan Mohammadi, Pardis Sadeghipour, Homa Abri, Sanaz Tabrizi, S. Mousavian, Shaghayegh Shahmirzaei, H. Bakhshandeh, Ahmad Amin, F. Rafiee, Elahe Baghizadeh, B. Mohebbi, Seyed Ehsan Parhizgar, Rasoul Aliannejad, Vahid Eslami, Alireza Kashefizadeh, Hessam Kakavand, Seyed Hossein Hosseini, S. Shafaghi, S. Ghazi, A. Najafi, David Jiménez, Aakriti Gupta, Mahesh V. Madhavan, S. Sethi, S. Parikh, M. Monreal, N. Hadavand, Alireza Hajighasemi, Majid Maleki, S. Sadeghian, G. Piazza, Ajay J. Kirtane, B. V. Van Tassell, P. Dobesh, Gregg W. Stone, G. Lip, H. Krumholz, S. Goldhaber, B. Bikdeli +59 moresemanticscholar +1 more source
